Lo Francisinsider trades
In SEC Form 4 filings, Lo Francis is listed as Chief People Officer of Adaptive Biotechnologies Corp (ADPT). In the last 90 days, Lo Francis sold $4.00M of Adaptive Biotechnologies Corp (ADPT) on the open market and bought none. All 4 sales were reported under a 10b5-1 trading plan.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| ADPTAdaptive Biotechnologies Corp | Chief People Officer | 18 | Oct 5 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-09-18
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| ADPTAdaptive Biotechnologies Corp | Oct 1 | Oct 5 | M | 8,038 | $8.46 | $68,001 | 228,905 | Yes | Form 4 |
| ADPTAdaptive Biotechnologies Corp | Oct 1 | Oct 5 | M | 9,377 | $3.99 | $37,414 | 238,282 | Yes | Form 4 |
| ADPTAdaptive Biotechnologies Corp | Oct 1 | Oct 5 | M | 9,377 | $8.12 | $76,141 | 247,659 | Yes | Form 4 |
| ADPTAdaptive Biotechnologies Corp | Oct 1 | Oct 5 | S | 8,094 | $27.52 | Sale −$222,747 | 239,565 | Yes | Form 4 |
| ADPTAdaptive Biotechnologies Corp | Oct 1 | Oct 5 | S | 18,698 | $28.61 | Sale −$534,950 | 220,867 | Yes | Form 4 |
| ADPTAdaptive Biotechnologies Corp | Oct 1 | Oct 5 | M · derivative | 8,038 | $8.46 | $68,001 | 16,075 | Yes | Form 4 |
| ADPTAdaptive Biotechnologies Corp | Oct 1 | Oct 5 | M · derivative | 9,377 | $3.99 | $37,414 | 56,259 | Yes | Form 4 |
| ADPTAdaptive Biotechnologies Corp | Oct 1 | Oct 5 | M · derivative | 9,377 | $8.12 | $76,141 | 93,765 | Yes | Form 4 |
| ADPTAdaptive Biotechnologies Corp | Sep 16 | Sep 18 | M | 53,091 | $12.14 | $644,525 | 283,804 | Yes | Form 4 |
| ADPTAdaptive Biotechnologies Corp | Sep 16 | Sep 18 | M | 13,398 | $8.46 | $113,347 | 297,202 | Yes | Form 4 |
| ADPTAdaptive Biotechnologies Corp | Sep 16 | Sep 18 | M | 15,629 | $3.99 | $62,360 | 312,831 | Yes | Form 4 |
| ADPTAdaptive Biotechnologies Corp | Sep 16 | Sep 18 | M | 23,442 | $8.12 | $190,349 | 336,273 | Yes | Form 4 |
| ADPTAdaptive Biotechnologies Corp | Sep 16 | Sep 18 | S | 107,537 | $28.02 | Sale −$3,013,187 | 228,736 | Yes | Form 4 |
| ADPTAdaptive Biotechnologies Corp | Sep 16 | Sep 18 | S | 7,869 | $28.57 | Sale −$224,817 | 220,867 | Yes | Form 4 |
| ADPTAdaptive Biotechnologies Corp | Sep 16 | Sep 18 | M · derivative | 53,091 | $12.14 | $644,525 | 79,155 | Yes | Form 4 |
| ADPTAdaptive Biotechnologies Corp | Sep 16 | Sep 18 | M · derivative | 13,398 | $8.46 | $113,347 | 24,113 | Yes | Form 4 |
| ADPTAdaptive Biotechnologies Corp | Sep 16 | Sep 18 | M · derivative | 15,629 | $3.99 | $62,360 | 65,636 | Yes | Form 4 |
| ADPTAdaptive Biotechnologies Corp | Sep 16 | Sep 18 | M · derivative | 23,442 | $8.12 | $190,349 | 103,142 | Yes | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.